Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 510,695	$ 868,067
Short-term investment	39,283	39,249
Accounts receivable, net	449,110	284,395
Costs and estimated earnings in excess of billings on uncompleted contracts	157,871	36,476
Inventory	81,541	48,011
Prepaid expenses and other current assets	3,493	1,405
Total current assets	1,241,993	1,277,603
Equipment, net	7,583	6,064
Debt issuance costs, net	112,075	103,632
Totals	1,361,651	1,387,299
Current liabilities:
Accounts payable and accrued expenses	327,170	343,080
Accrued interest, related party	22,460	20,439
Accrued interest	30,240
Related party accounts payable and accrued expenses	52,010	102,856
Related party notes payable	73,500	73,500
Billings in excess of costs and estimated earnings on uncompleted contracts	143,124	69,789
Deferred revenue	201,117	201,117
Conversion option liabilities	31,021	69,502
Warrant liabilities	250,296	337,055
Total current liabilities	1,130,938	1,217,338
Convertible debentures, net	1,036,531	685,692
Total liabilities	2,167,469	1,903,030
Commitments
Stockholders' deficiency:
Preferred stock, $0.01 par value, 5,000,000 shares authorized; 0 issued and outstanding at March 31, 2013 and December 31, 2012
Common stock, $0.01 par value, 100,000,000 shares authorized; 42,198,093 issued and outstanding at March 31, 2013and December 31, 2012	421,981	421,981
Additional paid-in capital	6,215,978	6,099,635
Accumulated deficiency	(7,444,242)	(7,036,776)
Accumulated other comprehensive loss	465	(571)
Total stockholders' deficiency	(805,818)	(515,731)
Totals	$ 1,361,651	$ 1,387,299